Hem › Post-COVID-tillstånd (Long COVID) › Washington
Kliniska studier för Post-COVID-tillstånd (Long COVID) i Washington
5 studier för Post-COVID-tillstånd (Long COVID) söker deltagare vid platser i Washington.
Städer i Washington
Officiell studietext (engelska)
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- Eastside Research Associates ( Site 3727), Redmond
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 5 okt. 2026 · NCT06667700A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Seattle Rheumatology Associates, Seattle
- Swedish Ambulatory Infusion Center- First Hill, Seattle
- Swedish Cancer Institute Treatment Center, Seattle
- och 6 fler
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07013474Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
- Swedish Medical Center, Seattle
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06631287A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
- GSK Investigational Site, Seattle
RekryterarFas 1
Ålder 65 till 85 · Alla kön · Uppdaterad 30 juni 2026 · NCT07464314Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- Seattle Children's Hospital, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Fred Hutchinson Cancer Research Center, Seattle
RekryterarFas 3
Alla åldrar · Alla kön · Uppdaterad 23 juni 2026 · NCT03808922Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.